FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3209915372> ?p ?o ?g. }

• W3209915372 endingPage "1181" @default.
• W3209915372 startingPage "1181" @default.
• W3209915372 abstract "Philadelphia-negative myeloproliferative neoplasms (MPN) are aggressive diseases characterized by clonal proliferation of myeloid stem cells. The clonal process leads to excessive red cells production, platelets production, and bone marrow fibrosis. According to the phenotype, MPN can be classified as polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). MPN patients have shortened survival due to the increased risk of thrombosis, hemorrhages, and transformation to acute myeloid leukemia (AML). Prognosis is variable, with a shorter life expectancy in myelofibrosis. Currently, drug therapy can reduce symptoms, splenomegaly, and risk of thrombosis. Still, some patients can be resistant or intolerant to the treatment. At the same time, allogeneic stem cell transplant (ASCT) is the only treatment modality with the potential to cure the disease. Nevertheless, the ASCT is reserved for high-risk leukemic progression patients due to the risk of treatment-related death and comorbidity. Therefore, there is a need for new drugs that can eradicate clonal hematopoiesis and prevent progression to more aggressive myeloid neoplasms. Thanks to the better understanding of the disease's molecular pathogenesis, many new potentially disease-modifying drugs have been developed and are currently in clinical trials. This review explores the most promising new drugs currently in clinical trials." @default.
• W3209915372 created "2021-11-08" @default.
• W3209915372 creator A5079398488 @default.
• W3209915372 date "2021-10-31" @default.
• W3209915372 modified "2023-09-26" @default.
• W3209915372 title "New Horizons in Myeloproliferative Neoplasms Treatment: A Review of Current and Future Therapeutic Options" @default.
• W3209915372 cites W1148460347 @default.
• W3209915372 cites W1534089060 @default.
• W3209915372 cites W1653629301 @default.
• W3209915372 cites W1754059962 @default.
• W3209915372 cites W1916256621 @default.
• W3209915372 cites W1963736125 @default.
• W3209915372 cites W1963876174 @default.
• W3209915372 cites W1975106942 @default.
• W3209915372 cites W1976651396 @default.
• W3209915372 cites W1977590248 @default.
• W3209915372 cites W1980568348 @default.
• W3209915372 cites W1989336431 @default.
• W3209915372 cites W1990900213 @default.
• W3209915372 cites W1995370367 @default.
• W3209915372 cites W2003535009 @default.
• W3209915372 cites W2006787224 @default.
• W3209915372 cites W2008799537 @default.
• W3209915372 cites W2024401882 @default.
• W3209915372 cites W2030868349 @default.
• W3209915372 cites W2031978224 @default.
• W3209915372 cites W2049145190 @default.
• W3209915372 cites W2049965335 @default.
• W3209915372 cites W2053961852 @default.
• W3209915372 cites W2056777053 @default.
• W3209915372 cites W2057360098 @default.
• W3209915372 cites W2059065213 @default.
• W3209915372 cites W2066509853 @default.
• W3209915372 cites W2067829130 @default.
• W3209915372 cites W2072881492 @default.
• W3209915372 cites W2073889874 @default.
• W3209915372 cites W2078972833 @default.
• W3209915372 cites W2085404468 @default.
• W3209915372 cites W2093216476 @default.
• W3209915372 cites W2093657334 @default.
• W3209915372 cites W2097743943 @default.
• W3209915372 cites W2099366696 @default.
• W3209915372 cites W2101004361 @default.
• W3209915372 cites W2105496815 @default.
• W3209915372 cites W2116878961 @default.
• W3209915372 cites W2116957649 @default.
• W3209915372 cites W2123587611 @default.
• W3209915372 cites W2126665281 @default.
• W3209915372 cites W2138709799 @default.
• W3209915372 cites W2139860886 @default.
• W3209915372 cites W2144664431 @default.
• W3209915372 cites W2339658711 @default.
• W3209915372 cites W2405712018 @default.
• W3209915372 cites W2557590973 @default.
• W3209915372 cites W2558311129 @default.
• W3209915372 cites W2558736960 @default.
• W3209915372 cites W2559551701 @default.
• W3209915372 cites W2563465351 @default.
• W3209915372 cites W2564597498 @default.
• W3209915372 cites W2586215211 @default.
• W3209915372 cites W2589237569 @default.
• W3209915372 cites W2598479043 @default.
• W3209915372 cites W2612296054 @default.
• W3209915372 cites W2622547803 @default.
• W3209915372 cites W2754551124 @default.
• W3209915372 cites W2759277150 @default.
• W3209915372 cites W2778275419 @default.
• W3209915372 cites W2791464448 @default.
• W3209915372 cites W2801709198 @default.
• W3209915372 cites W2883135363 @default.
• W3209915372 cites W2898695740 @default.
• W3209915372 cites W2900721542 @default.
• W3209915372 cites W2946901694 @default.
• W3209915372 cites W2952331001 @default.
• W3209915372 cites W2976755053 @default.
• W3209915372 cites W2986211227 @default.
• W3209915372 cites W2987026504 @default.
• W3209915372 cites W2990530712 @default.
• W3209915372 cites W2990940822 @default.
• W3209915372 cites W2991379201 @default.
• W3209915372 cites W2998901800 @default.
• W3209915372 cites W3000101033 @default.
• W3209915372 cites W3003423609 @default.
• W3209915372 cites W3081986678 @default.
• W3209915372 cites W3087687780 @default.
• W3209915372 cites W3088387990 @default.
• W3209915372 cites W3097774410 @default.
• W3209915372 cites W3102785656 @default.
• W3209915372 doi "https://doi.org/10.3390/medicina57111181" @default.
• W3209915372 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8619471" @default.
• W3209915372 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34833399" @default.
• W3209915372 hasPublicationYear "2021" @default.
• W3209915372 type Work @default.
• W3209915372 sameAs 3209915372 @default.
• W3209915372 citedByCount "0" @default.
• W3209915372 crossrefType "journal-article" @default.
• W3209915372 hasAuthorship W3209915372A5079398488 @default.
• W3209915372 hasBestOaLocation W32099153721 @default.

• next